---
title: "Beilu Pharma: Haichang Pharmaceutical has obtained GMP certification from the Brazilian National Health Surveillance Agency"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/255564498.md"
description: "According to the Zhitong Finance APP, Beilu Pharma announced that its holding subsidiary Zhejiang Haichang Pharmaceutical Co., Ltd. (referred to as \"Haichang Pharmaceutical\") has officially passed the GMP (Good Manufacturing Practice) certification by the Brazilian National Health Surveillance Agency (referred to as \"Brazil ANVISA\")"
datetime: "2025-09-02T07:47:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/255564498.md)
  - [en](https://longbridge.com/en/news/255564498.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/255564498.md)
generator: "portal-rs"
---

# Beilu Pharma: Haichang Pharmaceutical has obtained GMP certification from the Brazilian National Health Surveillance Agency

According to the Zhitong Finance APP, Beilu Pharma (300016.SZ) announced that its controlling subsidiary Zhejiang Haichang Pharmaceutical Co., Ltd. (referred to as "Haichang Pharmaceutical") has passed the official on-site GMP (Good Manufacturing Practice) certification by the Brazilian National Health Surveillance Agency (referred to as "Brazil ANVISA")

### Related Stocks

- [300016.CN](https://longbridge.com/en/quote/300016.CN.md)

## Related News & Research

- [Promise Analyzes Telehealth Licensing Rules as Compact Hits Record 3,633 Licenses in a Month](https://longbridge.com/en/news/296635882.md)
- [Negative Link Announces Global Expansion and Next Phase of Growth](https://longbridge.com/en/news/296644416.md)
- [Curql invests in pet healthcare platform Wagmo](https://longbridge.com/en/news/296396050.md)
- [California helicopter maker wins major role in US Army pilot training](https://longbridge.com/en/news/296642218.md)
- [NATO members discuss Strait of Hormuz options without alliance involvement](https://longbridge.com/en/news/296639044.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**